The Fund aims to provide a high level of income together with long term capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 4.0% |
Diageo PLC | 3.7% |
Babcock International Group PLC | 3.2% |
Cable & Wireless PLC | 2.8% |
Smith & Nephew PLC | 2.8% |
Unilever PLC | 2.6% |
Melrose PLC | 2.5% |
Chemring Group PLC | 2.2% |
VT Group PLC | 2.2% |
Reed Elsevier PLC | 2.2% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 4.0% |
Diageo PLC | 3.7% |
Babcock International Group PLC | 3.2% |
Cable & Wireless PLC | 2.8% |
Other | 86.3% |
Date | 13-Nov-2024 |
---|---|
NAV | 164.20p |
Currency | GBP |
Change | -1.20p |
% | -0.73% |
YTD change | 6.50p |
YTD % | 4.12% |
Fund Inception | 06/05/2005 |
---|---|
Fund Manager | Matt Hudson |
TER | 1.23 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £25000 |
Additional | £500 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.07 |
You are here: research